Avecho Biotechnology wins US$3M deal with Sandoz for exclusive CBD insomnia... - published 27 Mar 2025 #ClinicalTrials #Australia #ltd #ASX #Tech
https://grafa.com/news/health-avecho-biotechnology-wins-us-3m-deal-with-sandoz-for-exclusive-cbd-insomnia-treatment-408231?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=408231

Avecho Biotechnology schließt einen Vertrag über 3 Millionen US-Dollar mit ... - published 27 Mar 2025 #ClinicalTrials #Australia #ltd #ASX #Tech
https://grafa.com/news/de-health-avecho-biotechnology-wins-us-3m-deal-with-sandoz-for-exclusive-cbd-insomnia-treatment-408263?utm_source=asx_news_de&utm_medium=mastodon&utm_campaign=408263

Septerna unveils corporate overview and 2024 financial results - published 27 Mar 2025 #today #ClinicalTrials #Tech #BioTech #Grafa
https://grafa.com/news/health-septerna-unveils-corporate-overview-and-2024-financial-results-407988?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=407988

Alterity Therapeutics completes Phase 2 open-label study for advanced MSA t... - published 27 Mar 2025 #ClinicalTrials #ltd #Tech #BioTech #Grafa
https://grafa.com/news/health-alterity-therapeutics-completes-phase-2-open-label-study-for-advanced-msa-treatment-407896?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=407896

Race Oncology ( #RAC ) has released " Race Initiates First AU Site for Phase 1 Solid Tumour Trial " on Thu 27 Mar at 15:53 AEST #ClinicalTrials #Australia #media #live #ltd
https://grafa.com/asset/race-oncology-ltd-3890-rac.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=rac.asx

Actinogen Medical ( #ACW ) has released " ACW conducts Type C meeting with FDA regarding depression " on Thu 27 Mar at 11:58 AEST #today #ClinicalTrials #Australia #media #live
https://grafa.com/asset/actinogen-medical-ltd-5264-acw.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=acw.asx

Alterity Therapeutics ( #ATH ) has released " Alterity Completes Last Patient Visit in Open-Label Trial " on Thu 27 Mar at 10:41 AEST #today #ClinicalTrials #Australia #media #ASX
https://grafa.com/asset/alterity-therapeutics-ltd-641-ath.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ath.asx

Neuren Pharmaceuticals treibt NNZ-2591 für die Behandlung von Hirnverletzun... - published 26 Mar 2025 #ClinicalTrials #News #ltd #ASX #Business
https://grafa.com/news/de-business-news-neuren-pharmaceuticals-advances-nnz-2591-for-newborn-brain-injury-treatment-407219?utm_source=asx_news_de&utm_medium=mastodon&utm_campaign=407219

Neuren Pharmaceuticals advances NNZ-2591 for newborn brain injury treatment - published 26 Mar 2025 #ClinicalTrials #News #ltd #ASX #Business
https://grafa.com/news/business-news-neuren-pharmaceuticals-advances-nnz-2591-for-newborn-brain-injury-treatment-407148?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=407148

Clinuvel Pharmaceuticals ( #CUV ) has released " CLINUVEL renews share buy-back program " on Thu 27 Mar at 09:03 AEST #tax #government #China #trading #ClinicalTrials
https://grafa.com/asset/clinuvel-pharmaceuticals-ltd-6512-cuv.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cuv.asx

Mereo BioPharma reports 2024 financial results and advances rare disease pi... - published 26 Mar 2025 #today #ClinicalTrials #Tech #Grafa #DeFi
https://grafa.com/news/health-mereo-biopharma-reports-2024-financial-results-and-advances-rare-disease-pipeline-406834?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=406834

What to do if #PubMed goes down the drain

The news from the US is unsettling, not least for medical information specialists. Siw Waffenschmidt, Head of our Department of Information Management, asks @hildabast, author of the blog 'Absolutely Maybe' and former NIH employee, for an assessment of the situation regarding PubMed and #ClinicalTrials.gov. How can all of us prepare for possible PubMed downtimes or deficiencies?

https://youtu.be/fn2paCE6Zco?si=atNcEhzfP3Ptbuuk

4Dmedical ( #4DX ) has released " Cost reduction program delivers $6.5m in annualised savings " on Wed 26 Mar at 09:58 AEST #today #tax #ArtificialIntelligence #NYSE #ClinicalTrials
https://grafa.com/asset/4dmedical-ltd-5186-4dx.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=4dx.asx

Clinuvel Pharmaceuticals ( #CUV ) has released " Positive preliminary results for PRENUMBRA Instant in stroke " on Wed 26 Mar at 09:15 AEST #today #tax #government #China #ClinicalTrials
https://grafa.com/asset/clinuvel-pharmaceuticals-ltd-6512-cuv.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=cuv.asx

Orthocell ( #OCC ) has released " First Sales of Striate in Germany, Austria & Swiss Region " on Wed 26 Mar at 09:02 AEST #ClinicalTrials #Australia #media #Strategy #ltd
https://grafa.com/asset/orthocell-ltd-177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx

Kezar Life Sciences reports positive results for zetomipzomib and 2024 fina... - published 25 Mar 2025 #today #ClinicalTrials #media #live #Tech
https://grafa.com/news/health-kezar-life-sciences-reports-positive-results-for-zetomipzomib-and-2024-financials-405779?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=405779

https://www.europesays.com/1940136/ What is glioblastoma, the aggressive brain cancer that killed former US Rep. Mia Love? #america #BarackObama #BeauBiden #BrainCancer #cancer #ClinicalTrials #DonaldTrump #GeneralNews #health #JoeBiden #JohnMcCain #MiaLove #MiaLoveWhat #NCStateWire #Politics #RobertTisch #SaltLakeCity #U.S.News #UnitedStates #UnitedStatesHouseOfRepresentatives #UnitedStatesOfAmerica #US #USNews #USTopics #USA #USANews #UTStateWire #Utah #YasmeenRauf

EBR Systems ( #EBR ) has released " 2024 Activity Report and Form 10-K submission " on Tue 25 Mar at 08:48 AEST #NYSE #ClinicalTrials #Australia #media #Strategy
https://grafa.com/asset/ebr-systems-inc-cdr-6751-ebr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ebr.asx

Eli Lilly will soon release key data on its weight loss pill orforglipron

https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html

UNITY Biotechnology announces positive Phase 2b trial results for UBX1325 i... - published 24 Mar 2025 #ClinicalTrials #Tech #BioTech #Grafa #Technology
https://grafa.com/news/health-unity-biotechnology-announces-positive-phase-2b-trial-results-for-ubx1325-in-diabetic-macular-edema-404715?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=404715